Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Christine, Gennigens"'
Autor:
Concetta Elisa Onesti, Hélène Schroeder, Andrée Rorive, Brieuc Sautois, Marie Lecocq, Marie Goffin, Elodie Gonne, Astrid Collinge, Laurence Nicolaers, Odile Wéra, Amandine Catot, Catherine Loly, Astrid Paulus, Anne Sibille, Laurence Lousberg, Florence Troisfontaine, Joëlle Collignon, Christine Gennigens, Pierre Frères, Marc Polus, Bernard Duysinx, Frédérique Vaillant, Nathalie Marchal, Aurélie Poncin, Guy Jerusalem
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background The spread of the COVID‐19 pandemic has led to a rapid reorganization in all human and hospital activities, with impact on cancer patients. Aim An analysis of cancer patients fears, and awareness of COVID‐19 has been done in t
Externí odkaz:
https://doaj.org/article/4801fa676c274876a0c7ba8b5957c880
Autor:
Sylvie Streel, Alixe Salmon, Adriane Dheur, Vincent Bours, Natacha Leroi, Lionel Habran, Katty Delbecque, Frédéric Goffin, Clémence Pleyers, Athanasios Kakkos, Elodie Gonne, Laurence Seidel, Frédéric Kridelka, Christine Gennigens
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4866 (2023)
Molecular algorithms may estimate the risk of recurrence and death for patients with endometrial cancer (EC) and may impact treatment decisions. To detect microsatellite instabilities (MSI) and p53 mutations, immunohistochemistry (IHC) and molecular
Externí odkaz:
https://doaj.org/article/e75b6a827ee7402b9fc65767e443da8c
Autor:
Christine Gennigens, Marjolein De Cuypere, Laurence Seidel, Johanne Hermesse, Annelore Barbeaux, Frédéric Forget, Adelin Albert, Guy Jerusalem, Frédéric Kridelka
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8432-8443 (2020)
Abstract Background Hemoglobin (Hb), white blood cell (WBC), and polymorphonuclear neutrophil (PMN) blood counts may be correlated with outcomes in patients with locally advanced cervical cancer. Methods Hb, WBC, and PMN counts were measured at diagn
Externí odkaz:
https://doaj.org/article/4bac52bfd9bf468d989bb0b7b939c19e
Autor:
Domenica Lorusso, Laurence Gladieff, Patricia Pautier, Christine Gennigens, Chuan Tian, Anna Kryzhanivska, Nawel Bourayou, Dominique Berton, Sulabha Ranganathan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/60ff1935fdf44a62b045d4df0f188814
Publikováno v:
Gland Surgery. 11:1832-1841
Autor:
Johanne Hermesse, Clémence Pleyers, Christine Gennigens, Marjolein De Cuypere, Pierre Lovinfosse, Laurence Seidel Statistician, Philippe Coucke, Frédéric Kridelka
Publikováno v:
Strahlentherapie und Onkologie. 199:141-148
This monocentric study aimed to assess the impact of technical advancement in brachytherapy (BT) on local control (LC) and cancer-specific survival (CSS) in locally advanced cervical cancer (LACC).Since 2010, 211 patients with LACC have been treated
Autor:
Robert L. Coleman, Ulrik Niels Lassen, Jeffrey R. Harris, Kristian Windfeld, Srinivas Ghatta, Reshma A. Rangwala, Fiona C. Thistlethwaite, Melissa L. Johnson, Christine Gennigens, Nathalie Cornez, Martin D. Forster, Robert Jones, James F. Spicer, Jean-Pascal Machiels, Hendrik-Tobias Arkenau, Yvette Drew, Brian M. Slomovitz, Johann S. de Bono, Ignace Vergote, Nicole Concin, David S. Hong
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c3d242be9bd2cff62fc2f7c9c1e709
https://doi.org/10.1158/1078-0432.22478142
https://doi.org/10.1158/1078-0432.22478142
Autor:
Robert L. Coleman, Ulrik Niels Lassen, Jeffrey R. Harris, Kristian Windfeld, Srinivas Ghatta, Reshma A. Rangwala, Fiona C. Thistlethwaite, Melissa L. Johnson, Christine Gennigens, Nathalie Cornez, Martin D. Forster, Robert Jones, James F. Spicer, Jean-Pascal Machiels, Hendrik-Tobias Arkenau, Yvette Drew, Brian M. Slomovitz, Johann S. de Bono, Ignace Vergote, Nicole Concin, David S. Hong
Purpose:Tissue factor (TF) is a potential target in cervical cancer, as it is frequently highly expressed and associated with poor prognosis. Tisotumab vedotin, a first-in-class investigational antibody–drug conjugate targeting TF, has demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f38b252c0896291d3186928e260eb23
https://doi.org/10.1158/1078-0432.c.6529863.v1
https://doi.org/10.1158/1078-0432.c.6529863.v1
Autor:
François Lucia, Vincent Bourbonne, Clémence Pleyers, Pierre-François Dupré, Omar Miranda, Dimitris Visvikis, Olivier Pradier, Ronan Abgral, Augustin Mervoyer, Jean-Marc Classe, Caroline Rousseau, Wim Vos, Johanne Hermesse, Christine Gennigens, Marjolein De Cuypere, Frédéric Kridelka, Ulrike Schick, Mathieu Hatt, Roland Hustinx, Pierre Lovinfosse
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Autor:
Ignace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, Christof Vulsteke, Caroline Lamot, Heidi Van den Bulck, Nele Claes, Marie-Pascale Graas, Guy Debrock, Isabelle Spoormans, Peter Vuylsteke, Brigitte Honhon, Didier Verhoeven, Daan De Maeseneer, Luc Dirix, Jeroen Mebis, Philippe Vroman, Hannelore Denys, Corina Martinez Mena, Gino Pelgrims, Mona Van Steenberghe, Toon van Gorp, Christine Gennigens
Publikováno v:
International journal of gynecological cancer
ObjectiveBecause elderly patients with ovarian cancer are underrepresented in randomized studies, this study aimed to expand our knowledge on the safety and effectiveness of frontline treatment with bevacizumab in combination with standard carboplati